Boston Children's Hospital (royalty interest in Vonvendi) Overview

  • Status
  • Private
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Boston Children's Hospital (royalty interest in Vonvendi) General Information

Description

A portfolio of royalty interest in a critical recombinant healthcare treatment therapy used to cure genetic bleeding disorder. The royalty interest is based on patented technology developed by researchers at Boston Children's and is marketed in the United States by Shire Plc.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Therapeutic Devices
Primary Office
  • 300 Longwood Avenue
  • Boston, MA 02115
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Boston Children's Hospital (royalty interest in Vonvendi) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Boston Children's Hospital (royalty interest in Vonvendi)‘s full profile, request access.

Request a free trial

Boston Children's Hospital (royalty interest in Vonvendi) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Boston Children's Hospital (royalty interest in Vonvendi)‘s full profile, request access.

Request a free trial